MOOMIN: Deep Molecular Omics Network for Anti-Cancer Drug Combination
  Therapy
  We propose the molecular omics network (MOOMIN) a multimodal graph neural
network used by AstraZeneca oncologists to predict the synergy of drug
combinations for cancer treatment. Our model learns drug representations at
multiple scales based on a drug-protein interaction network and metadata.
Structural properties of compounds and proteins are encoded to create vertex
features for a message-passing scheme that operates on the bipartite
interaction graph. Propagated messages form multi-resolution drug
representations which we utilized to create drug pair descriptors. By
conditioning the drug combination representations on the cancer cell type we
define a synergy scoring function that can inductively score unseen pairs of
drugs. Experimental results on the synergy scoring task demonstrate that MOOMIN
outperforms state-of-the-art graph fingerprinting, proximity preserving node
embedding, and existing deep learning approaches. Further results establish
that the predictive performance of our model is robust to hyperparameter
changes. We demonstrate that the model makes high-quality predictions over a
wide range of cancer cell line tissues, out-of-sample predictions can be
validated with external synergy databases, and that the proposed model is data
efficient at learning.
